- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection
Patent holdings for IPC class A61P 37/06
Total number of patents in this class: 6973
10-year publication summary
|
198
|
200
|
313
|
533
|
498
|
699
|
729
|
745
|
676
|
363
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10847 |
108 |
| The Regents of the University of California | 19898 |
73 |
| Chugai Seiyaku Kabushiki Kaisha | 1354 |
53 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
50 |
| F. Hoffmann-La Roche AG | 7930 |
45 |
| Selecta Biosciences, Inc. | 189 |
40 |
| Janssen Biotech, Inc. | 1552 |
38 |
| Bristol-myers Squibb Company | 4878 |
37 |
| Ono Pharmaceutical Co., Ltd. | 434 |
37 |
| Genentech, Inc. | 3971 |
36 |
| Astellas Pharma Inc. | 1085 |
35 |
| Eli Lilly and Company | 3841 |
35 |
| Takeda Pharmaceutical Company Limited | 2714 |
34 |
| Daiichi Sankyo Company, Limited | 1863 |
33 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
32 |
| Regeneron Pharmaceuticals, Inc. | 4255 |
32 |
| Osaka University | 3377 |
31 |
| Incyte Corporation | 1020 |
30 |
| The General Hospital Corporation | 4726 |
28 |
| Amgen Inc. | 4072 |
26 |
| Other owners | 6140 |